Evidence map›Paper›PMID 34903666›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Genome instability drives epistatic adaptation in the human pathogen

Giovanni Bussotti, Laura Piel, Pascale Pescher, Malgorzata A Domagalska, K Shanmugha Rajan, Smadar Cohen-Chalamish, Tirza Doniger, Disha-Gajanan Hiregange, Peter J Myler, Ron Unger and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Unraveling the Genome Diversity ofLife (Basel, Switzerland) · 2025
    Review
  8. Cross-subgenus hybridization betweenbioRxiv : the preprint server for biology · 2025
    Article
  9. Ribosomes: from conserved origin to functional/medical mobility and heterogeneity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  10. Article
  11. Article
  12. First comparative proteomic andFrontiers in veterinary science · 2025
    Article
  13. Genome analyses of amphotericin B-susceptible and -resistant strains ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  14. Article
  15. Article
  16. Molecular Mechanisms of Drug Resistance inPathogens (Basel, Switzerland) · 2024
    Review
  17. Genetic Variability in Leishmaniasis-CausingAnimals : an open access journal from MDPI · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Giovanni BussottiBioinformatics and Biostatistics Hub C3BI, Institut Pasteur, Université de Paris, Unité de Service et de Recherche (USR) 3756 Institut Pasteur CNRS, Paris 75015, France.ORCID 0000-0002-4078-7413
Laura PielUnité de Parasitologie moléculaire et Signalisation, Institut Pasteur, Université de Paris, INSERM U1201, Paris 75015, France.
Pascale PescherUnité de Parasitologie moléculaire et Signalisation, Institut Pasteur, Université de Paris, INSERM U1201, Paris 75015, France.
Malgorzata A DomagalskaMolecular Parasitology Unit, Institute of Tropical Medicine B-2000 Antwerp, Belgium.
K Shanmugha RajanThe Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan 52900, Israel.ORCID 0000-0003-4826-9802
Smadar Cohen-ChalamishThe Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan 52900, Israel.
Tirza DonigerThe Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan 52900, Israel.ORCID 0000-0001-6708-8404
Disha-Gajanan HiregangeDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Peter J MylerSeattle Structural Genomics Center for Infectious Disease, Seattle, WA 98195.
Ron UngerThe Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan 52900, Israel.ORCID 0000-0003-4153-3922
Shulamit MichaeliThe Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan 52900, Israel.
Gerald F SpäthUnité de Parasitologie moléculaire et Signalisation, Institut Pasteur, Université de Paris, INSERM U1201, Paris 75015, France; gerald.spaeth@pasteur.fr.ORCID 0000-0002-0256-2029
Bar-Ilan University · ILInserm · FRCentre National de la Recherche Scientifique · FRInfectious Disease Research Institute · USInstituut voor Tropische Geneeskunde · BEWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

How genome instability is harnessed for fitness gain despite its potential deleterious effects is largely elusive. An ideal system to address this important open question is provided by the protozoan pathogen

Indexed as

Epistasis, GeneticGenome, ProtozoanGenomic InstabilityAdaptation, PhysiologicalGene DosageGenetic FitnessHumansLeishmaniaLeishmaniasisepistatic interactionsevolutionary adaptationfitness gaingenome instabilityposttranscriptional regulation

Identifiers

PMID34903666
PMCPMC8713814
OpenAlexW4226068966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.